Dongying Li
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 8
- Cell Biology top 10%
- Microtubule and mitosis dynamics 3
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism 6
- Drug-Induced Hepatotoxicity and Protection 4
- Pharmacological Effects of Natural Compounds 3
-
- Antimicrobial Resistance in Staphylococcus 3
-
- Computational Drug Discovery Methods 5
Dongying Li
54 papers receiving 780 citations
Peers
Comparison fields: 5 of 125
- Cancer Research 176
- Cell Biology 134
- Pharmacology 66
- Molecular Biology 388
- Infectious Diseases 84
Countries citing papers authored by Dongying Li
This map shows the geographic impact of Dongying Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongying Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongying Li more than expected).
Fields of papers citing papers by Dongying Li
This network shows the impact of papers produced by Dongying Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongying Li. The network helps show where Dongying Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dongying Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 9 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 13 | |
| 11 | 2022 | 14 | |
| 12 | 2021 | 31 | |
| 13 | 2021 | 25 | |
| 14 | 2020 | 2 | |
| 15 | 2020 | 16 | |
| 16 | 2020 | 8 | |
| 17 | 2019 | 55 | |
| 18 | 2019 | 16 | |
| 19 | Regulation of cytochrome P450 expression by microRNAs and long noncoding RNAs: Epigenetic mechanisms in environmental toxicology and carcinogenesis | 2019 | 4 |
| 20 | 2016 | 55 |
About Dongying Li
Dongying Li is a scholar working on Pharmacology, Health Informatics and Cancer Research, having authored 59 papers that have together received 787 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (8 papers), Pharmacogenetics and Drug Metabolism (6 papers), Computational Drug Discovery Methods (5 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Microtubule and mitosis dynamics (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Pharmacological Effects of Natural Compounds (3 papers). The work is most often cited by research in Cancer Research (176 citations), Cell Biology (134 citations) and Pharmacology (66 citations). Dongying Li has collaborated with scholars based in China, United States and France. Frequent co-authors include Rytis Prekeris, Baitang Ning, Weida Tong, Lei Guo, Si Chen, William H. Tolleson, Dianke Yu, Louis Cicchini, Jie Bao and Ben Margolis. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Chemical Engineering Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.